HEALTH-RELATED QUALITY OF LIFE RESULTS FROM THE RANDOMIZED PHASE II TAVAREC TRIAL ON TEMOZOLOMIDE WITH OR WITHOUT BEVACIZUMAB IN 1p/19q INTACT FIRS RECURRENCE WHO GRADE II AND III GLIOMA (EORTC 26091)

Jaap C. Reijneveld, Corneel Coens, Martin J. B. Taphoorn, Peter Sillevis Smitt, Paul M. Clement, Ahmed Idbaih, Filip de Vos, Martin Klein, Wolfgang Wick, Paul Mulholland, Joanne Lewis, Vassilis Golfinopoulos, Andrew Bottomley, Martin van den Bent

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)203-203
JournalNeuro-Oncology
Volume19
Publication statusPublished - Nov 2017

Cite this